| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
68,728 |
47,937 |
$1.98M |
| 99215 |
Prolong outpt/office vis |
45,417 |
27,756 |
$1.45M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
129 |
90 |
$444K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
696 |
216 |
$424K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
102,823 |
66,397 |
$318K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,878 |
6,468 |
$212K |
| 99233 |
Prolong inpt eval add15 m |
7,695 |
2,289 |
$169K |
| 77427 |
|
1,648 |
558 |
$100K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,730 |
1,270 |
$54K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
681 |
527 |
$36K |
| 77014 |
|
2,295 |
159 |
$32K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
629 |
353 |
$25K |
| 77334 |
|
246 |
125 |
$24K |
| 96367 |
|
1,037 |
511 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,117 |
1,347 |
$12K |
| 99223 |
Prolong inpt eval add15 m |
382 |
294 |
$9K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
12,621 |
7,369 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
277 |
157 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
30,837 |
18,448 |
$7K |
| 99222 |
Initial hospital care, per day, moderate complexity |
180 |
161 |
$4K |
| 99205 |
Prolong outpt/office vis |
71 |
66 |
$4K |
| J1756 |
Injection, iron sucrose, 1 mg |
56 |
32 |
$3K |
| 88185 |
|
28 |
27 |
$3K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
31 |
12 |
$3K |
| 85027 |
|
1,193 |
853 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
173 |
105 |
$2K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
71 |
38 |
$2K |
| 77300 |
|
14 |
12 |
$956.66 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$876.73 |
| 77263 |
|
18 |
12 |
$453.38 |
| 85097 |
|
20 |
14 |
$393.68 |
| 88184 |
|
28 |
27 |
$347.79 |
| 99459 |
|
46 |
44 |
$308.93 |
| G9678 |
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement |
917 |
734 |
$184.00 |
| 88189 |
|
12 |
12 |
$146.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
136 |
64 |
$121.78 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
268 |
97 |
$107.19 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
19 |
14 |
$87.55 |
| S0028 |
Injection, famotidine, 20 mg |
40 |
24 |
$71.16 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
90 |
51 |
$64.36 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
44 |
24 |
$34.56 |
| J3490 |
Unclassified drugs |
36 |
12 |
$3.00 |